CellarisBio
CellarisBio is a cellular biophysics company pioneering MICRO-TAG® cellular target engagement technology for next-generation drug discovery. MICRO-TAG® transforms drug discovery by enabling quantitative, real-time measurement of complex drug-target interactions directly in cells. Backed by multiple patents, CellarisBio is focused on unlocking challenging target classes, including membrane proteins, transcription factors, protein complexes and other intrinsically disordered proteins, many of which were previously considered “undruggable.” The MICRO-TAG® platform enables high-resolution cellular target engagement analysis across temperature-series workflows, providing mechanistic insights beyond conventional endpoint assays. Applications of MICRO-TAG® include hit discovery and validation, Cellular DEL discovery and functional mechanism-of-action studies, spanning multiple therapeutic modalities and target families. CellarisBio has also recently released a panel of MICRO-TAG® research reagents designed to provide streamlined access to real-time cellular target engagement workflows for research labs.Content by CellarisBio
Page 1 of 1 - 1 Total Items
